Home » SIRION THERAPEUTICS SETS ITS SIGHTS ON OPHTHALMIC HEALTH
SIRION THERAPEUTICS SETS ITS SIGHTS ON OPHTHALMIC HEALTH
Founded with a mission to protect and preserve the gift of sight, executives from the newly created Sirion Therapeutics, Inc. unveiled their new company today. The announcement was made by co-founders Barry Butler, Chairman and Chief Executive Officer; Roger
Vogel, MD, Chief Medical Officer; Susan Benton, Chief Commercial Officer; and
Philippe Boulangeat, Chief Business Officer.
PR
Newswire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May